NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
Published by: Aaron Brown, Sr. Manager, Market Intelligence Insights
Since the FDA and NIH signaled their pivot toward New Approach Methodologies
As many subscribers have described it, IBO is analogous to The Wall Street Journal for the analytical instruments industry. Not only does IBO provide news briefings, but it offers viewpoints and strategic analysis of important market events.
Instrument Business Outlook is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the analytical & life science instruments markets. IBO delivers the latest industry events, trends and SDi data and analysis in an easy to read format with graphs and tables to deliver the maximum in industry insight with a minimum time investment for executives and investors.
Annual Subscriptions (24 Issues)
Electronic Subscriptions
The Science Advisory Board is an expert network of more than 40,000 scientists engaged in biological research, drug discovery and biopharmaceutical production. Our members are available to participate in periodic studies about your products and services.